Patent 5019075 Issued on May 28, 1991. Estimated Expiration Date: July 31, 2010. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
606/7, Angioplasty604/913, DILATORS MADE OF SWELLABLE MATERIAL [A61M 29/02]606/15, With optical fiber606/28, Tip or other heat concentration means606/194, Inserted in vascular system607/89, Laser application607/92Internal application
The region surrounding the balloon utilized in percutaneous transluminal coronary angioplasty is heated by means within the balloon or within the skin of the balloon upon inflation of the balloon such that disrupted tissues of the plaque in the arterial wall are heated in order to fuse together fragmented segments of tissue and to coagulate blood trapped within dissected planes of tissue and within fissures created by wall fracture such that upon subsequent balloon deflation a smooth cylindrically-shaped channel results, thereby to prevent collapse of any flap of material which could cause either abrupt arterial closure and an acute myocardial infarction or gradual restenosis at the site of balloon inflation.
Dew, 1983, "Laser Assisted Microsurgical Repair of Soft Tissue: An Update and Review"
Dew, 6/84, "Laser Microsurgical Repair of Soft Tissue: A Demonstration of Surgical Technique"
Dries, 6/84
Eugene, 6/84
Fasano, 6/84
Geschwinn, 11/12/83
Gorisch, 1982
Gruntzig, 7/12/79
Hecht, 4/88
Jain, 6/84, "Sutureless Anastomosis . . . "
Jain, 6/84, "Laser Angioplasty . . . "
Krueger, 1985
Lawrence, 6/84
Ledor, 6/84
Lee, 12/81, "Laser-Dissolution . . . "
Lee, 10/83, "The Use of Dual Fiberoptic Catheter . . . "
Lee, 7/1/85, "Limitations, Risks and Complications . . . "
Linkser, 1984
Protell, 2/78
Quigley, 1985
Sauer, 5/85
Serur, "Laser Balloon Angioplasty . . . "
Spears, 1983, "In Vivo Coronary Angioplasty"
Spears, 1985, "Coronary Angioplasty During Cardiac Catherterization"
Spears, 1986, "Potential Role of Laser in the Cardiac Catheterization Laboratory"
van Gemert, 5/85
Ward, 1984
White, 5/85
Author Unknown, 6/84, "Sutureless Microvascular Extra-Crania Anastomosis with Nd:YAG Laser"
Aqueous Peroxyoxalate Chemiluminescence, Final Report to the Office of Naval Research, Contract N00014-77-C-0634, A. Mohan et al., Discovery Research Department, Chemical Research Div. American Cyanamid Company, Bound Brook, N.J., pp. 1-156, (Jan. 1982)
"Atherosclerosis", H. Wolinsky, Cardiovascular Diseases (U.S.A.), vol. XIV, pp. 1218-1222
"The Photodynamic Properties of a Particular Hematoporphyrin Derivative", R. Lipson et al., Archives of Dermatology (U.S.A.), vol. 82, No. 4, pp. 76/508-84/516, (1960)
"Hematoporphyrin Derivative for Detection and Management of Cancer", R. Lipson et al., Cancer (U.S.A.), vol. 20, No. 12, pp. 225-2257, (Dec. 1967)
R. Lipson et al., "The Use of a Derivative of Hematoporphyrin in Tumor Detection", Journal of the National Cancer Institute, vol. 26, No. 1, pp. 1-18, (Jan. 1961)
D. Sanderson et al., "Hematoporphyrin as a Diagnostic Tool", Cancer (U.S.A.), vol. 30, No. 5, pp. 1368-1372, (Nov. 1972)
T. Dougherty et al., "Photoradiation in the Treatment of Recurrent Breast Carcinom", Journal National Cancer Institute (U.S.A.), vol. 62, No. 2, pp. 231-237, (Feb. 1979)
T. Sery, "Photodynamic Killing of Retinoblastom Cells with Hematoporphyrin and Light", Cancer Research (U.S.A.), vol. 39, pp. 96-100, (Jan. 1979)
J. Moan et al., "The Mechanism of Photodynamic Inactivation of Human Cells In Vitro in the Presence of Haematoporphyrin", British Journal of Cancer, vol. 39, No. 4, pp. 398-407, (1979)
F. Gollan et al., "Oxygen Transport of Colloidal Fluorocarbon Suspensions in Asanguineous Rabbits", American Journal of Physiology (U.S.A.), vol. 229, No. 4, pp. 1045-1049, (Oct. 1975)
K. Kanter et al., "Superiority of Perlouorocarbon Cardiopegia Over Blood or Crystalloid Cardioplegia", Circulation (U.S.A.), vol. 64, Supplement II, pp. II-75-II-80, (Aug. 1981)
J. Spears et al., "Fluorescence of Experimental Atheromatous Plaques with Hematoporphyrin Derivative", Journal of Clinical Investigation (U.S.A.), vol. 71, pp. 395-399, (Feb. 1983
July 31, 2010. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
